Acrc Trials
Plano, Texas 75093
2 studies enrolling now · 16 studies all time
What they study most
Actinic Keratosis, Acute Gastroenteritis, Atopic Dermatitis, COVID-19, Episodic Migraine, Hyperhidrosis, Hypertension, Influenza, Meningococcal Vaccine, Migraine, Migraine Disorders, Non-segmental Vitiligo
Studies at this site
- A Study of Zasocitinib in Adults With Nonsegmental Vitiligo — Recruiting now
- A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo — Recruiting now
- A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19 — Completed
- A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis — Running, not enrolling
- Efficacy and Safety of NVX-CoV2705 — Running, not enrolling
- A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age — Running, not enrolling
- A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen — Completed
- B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis — Completed
- A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine — Completed
- A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age. — Completed
- Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis — Completed
- An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine — Completed
- Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis — Completed
- Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza — Completed
- A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp — Completed
- A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR) — Completed